Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/IIa trial of allogeneic expanded adipose-derived stem cells for Crohn rectovaginal fistulas
2009-010225-39Phase 2Completed
- Sponsor
- FIBHULP
- Start
- Feb 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of darvadstrocel in Crohn's disease and rectovaginal fistula (RVF) (2 arms), sponsored by FIBHULP. Primary endpoints: Feasibility and safety and Cumulative incidence of therapy-attributed adverse effects. Started Feb 2010; status: completed.
02
Drugs
darvadstrocel
03
Conditions
Crohn's diseaserectovaginal fistula (RVF)
Beyond the preview
Go deeper on 2009-010225-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010225-39.